debrisoquin has been researched along with bunitrolol in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Huang, Y; Masubuchi, Y; Mizukami, T; Narimatsu, S; Suzuki, T | 2 |
Horie, T; Masubuchi, Y; Narimatsu, S; Suzuki, T; Yamamoto, K | 1 |
Funk, C; Haddad, S; Poulin, P | 1 |
5 other study(ies) available for debrisoquin and bunitrolol
Article | Year |
---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Development of a high-performance liquid chromatographic method for the analysis of enatiomer/enantiomer interaction in oxidative metabolism of bunitrolol in rat liver microsomes.
Topics: Adrenergic beta-Antagonists; Animals; Chromatography, High Pressure Liquid; Debrisoquin; Gas Chromatography-Mass Spectrometry; Male; Microsomes, Liver; Oxidation-Reduction; Propanolamines; Quinidine; Quinine; Rats; Rats, Wistar; Stereoisomerism | 1994 |
Characterization of the oxidation reactions catalyzed by CYP2D enzyme in rat renal microsomes.
Topics: Animals; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Debrisoquin; Female; Kidney; Male; Microsomes; Mixed Function Oxygenases; Oxidation-Reduction; Propanolamines; Rats; Rats, Wistar; Substrate Specificity | 1996 |
In-vitro metabolic interaction of bunitrolol enantiomers in rabbit liver microsomes.
Topics: Adrenergic beta-Antagonists; Animals; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Debrisoquin; Female; Hydroxylation; In Vitro Techniques; Kinetics; Male; Microsomes, Liver; Propanolamines; Quinidine; Quinine; Rabbits; Rats; Rats, Wistar; Species Specificity; Stereoisomerism | 1996 |
Extrapolating in vitro metabolic interactions to isolated perfused liver: predictions of metabolic interactions between R-bufuralol, bunitrolol, and debrisoquine.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Debrisoquin; Drug Interactions; Ethanolamines; In Vitro Techniques; Liver; Propanolamines; Rats | 2010 |